Thermo Fisher Scientific Commits to Achieve Net-Zero Carbon Emissions by 2050
July 27, 2021
Accelerated efforts align with the Paris Agreement and Race To Zero to combat climate change WALTHAM, Mass. -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced its commitment to achieve net-zero carbon emissions by 2050. This supports the global goals of the Paris Climate Agreement and the United Nations' [...]
ERS Genomics and Japan SLC sign CRISPR/Cas9 license agreement
July 27, 2021
Nobel prize winning CRISPR technology to be applied in development of genetically engineered animal models Dublin, Ireland & Shizuoka, Japan: ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property co-owned by Dr. Emmanuelle Charpentier, and Japan SLC, Inc., a biotechnology company providing animal models to the research community, today [...]
July 26, 2021
HOUSTON--(BUSINESS WIRE)--Jul. 26, 2021-- Kiromic Biopharma, Inc. (Nasdaq: KRBP), a pioneer in immuno oncology cellular therapy in solid tumors, is pleased to announce it has completed the acquisition of InSilico Solutions. InSilico Solutions is a world-class bio-informatics and artificial intelligence innovator with a long standing collaborative relationship with its clients at MD Anderson Cancer Center, Johns Hopkins School of [...]
Porvair Increase Porous Plastics Manufacturing Capacity
July 26, 2021
Porvair Sciences reports on the installation of new automated precision die-cutting equipment that has enabled a five-fold increase in its production capacity for porous plastic components. This major investment by the company is in response to a significant rise in demand from customers for precision components made from its high performance Vyon® porous plastics. Installed [...]
Appointment of Mr. Alan Malus and Ms. Kyoko Deguchi as Independent External Directors
July 26, 2021
TOKYO – PHC Holdings Corporation (headquarters: Minato-ku, Tokyo, Japan, President & CEO: John Marotta, hereafter PHCHD), a leading global healthcare company, has today announced the appointment of Alan Malus and Kyoko (Kay) Deguchi as independent external directors, effective June 30, 2021. Both bring extensive knowledge of the healthcare industry and executive-level experience at international and [...]
Scintica and Baker Ruskinn Announce New Extended Partnership
July 26, 2021
Scintica is excited to announce its new and extended distribution agreement with Baker Ruskinn, global leader and supplier of anaerobic and modified atmosphere solutions for microbiology and tissue/cell culture applications. The Baker Company, global leader in containment technology, owner of Baker Ruskinn, itself a global leader in anaerobic and precision low-oxygen culture solutions for microbiology [...]
Twist Bioscience Incorporates MOLCURE AI Technology to Augment Therapeutic Antibody Discovery
July 26, 2021
SOUTH SAN FRANCISCO, Calif. & KAWASAKI, Japan -- Twist Bioscience Corporation (Nasdaq: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and MOLCURE Inc., today announced they generated potent, binding antibodies to an undisclosed oncology target for Twist’s internal pipeline of antibody candidates. The collaborative research [...]
July 26, 2021
Burlingame, California — Collaborative Drug Discovery, Inc. (CDD), provider of the web-based drug discovery informatics platform CDD Vault, announces the launch of a new data offering named BioHarmony. BioHarmony provides semantically curated live feeds of drug data from diverse sources. Often researchers may focus too narrowly on one aspect of a problem, however by culling data [...]
Vizgen, Spatial Genomics Innovator, Expands Leadership Team
July 26, 2021
Vizgen, Spatial Genomics Innovator, Expands Leadership Team Leader in spatially resolved, single-cell transcriptomics appoints Bob Koshgarian as VP of Operations, advancing company towards MERSCOPE™ commercialization CAMBRIDGE, Mass. —Vizgen, the life science company dedicated to improving human health by visualizing single-cell spatial genomics information, has announced that Bob Koshgarian has joined the leadership team as Vice President of [...]
PerkinElmer to Acquire Antibody and Reagent Leader BioLegend
July 26, 2021
Transformative deal significantly scales leading position in life science to accelerate legendary discoveries in precision medicine Leader in antibody development with highly complementary, innovative portfolio in emerging, high-growth areas of biologics, cell and gene therapy, proteogenomics, and recombinant proteins Commercial synergy opportunity to accelerate life science growth with potential benefits for diagnostics franchise Annual BioLegend revenues of [...]

